anti-NA antibody product blog
Tags: Antibody; Polyclonal Antibody; anti-NA antibody; H1N1 Neuraminidase;
The NA na (Catalog #MBS151366) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The H1N1 Neuraminidase Antibody reacts with Virus and may cross-react with other species as described in the data sheet. MyBioSource\'s H1N1 Neuraminidase can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA).Neuraminidase antibody can be used for the detection of the Neuraminidase protein from the seasonal influenza A (H1N1) and the novel swine influenza in ELISA. It will detect 2 ng of free peptide at 1 mug/mL. Researchers should empirically determine the suitability of the NA na for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The NA na product has the following accession number(s) (GI #168827347) (NCBI Accession #ACA33620) (Uniprot Accession #B1AGS8). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the H1N1 Neuraminidase Antibody with the following immunoassay(s):
ELISA (EIA) (ELISA results using H1N1 Neuraminidase antibody at 1 μg/mL and the blocking and corresponding peptides at 50, 10, 2 and 0 ng/mL.)
H1N1 Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.
Conjugate: Unconjugated
Immunogen: Neuraminidase antibody was raised against synthetic peptides from. The seasonal influenza (H1N1) Neuraminidase protein and the novel swine influenza Neuraminidase protein.
The antibody recognizes both variants.
Buffer: H1N1 Neuraminidase Antibody is supplied in PBS containing 0.02% sodium azide.